Orforglipron Before Surgery: What to Know

If you’re scheduled for surgery, an endoscopy, or any procedure involving general anesthesia or deep sedation, tell the team you’re taking orforglipron (Foundayo) as soon as it’s scheduled. The FDA-approved label notes that GLP-1 receptor agonists — orforglipron included — slow stomach emptying, and there have been rare reports of pulmonary aspiration in people on this drug class undergoing procedures under anesthesia. This isn’t a reason to panic, and it isn’t a reason to stop the medication on your own — it’s a reason to loop in your surgical team early.

Why orforglipron matters before a procedure

Orforglipron is a GLP-1 receptor agonist, and slowing gastric emptying is part of how the drug class reduces appetite — food sits in the stomach longer, which contributes to feeling fuller. That same effect is relevant to anesthesia: standard preoperative fasting rules assume your stomach empties at a typical rate, and a slower rate means there’s a chance of more residual stomach contents than expected, even after following the usual fasting window.

What the FDA label actually says

Per the FOUNDAYO label on DailyMed, there have been rare postmarketing reports of pulmonary aspiration in patients taking GLP-1 receptor agonists who underwent elective surgery or procedures requiring general anesthesia or deep sedation — including some patients who reported following standard preoperative fasting recommendations. The label is also explicit about what isn’t yet established: available data are insufficient to say whether modifying preoperative fasting or temporarily stopping orforglipron actually reduces that risk. In other words, there’s no FDA-verified protocol to follow here — which is exactly why this is a conversation for your surgical team rather than a rule you can look up and apply yourself. The label’s instruction to patients is straightforward: tell your healthcare providers before any planned surgery or procedure that you’re taking orforglipron.

Should you stop orforglipron before surgery?

This isn’t a question this article — or any general guide — can answer for you. Whether to continue, pause, or adjust the timing of a GLP-1 medication around a procedure depends on the type of procedure, the anesthesia plan, how long you’ve been on the medication, where you are in dose titration, and your individual risk factors, all of which only your surgical team and prescriber can weigh together. Don’t stop, skip, or adjust your orforglipron dose ahead of a procedure based on something you read online, including this article — get instructions directly from the people managing your surgery.

What to actually do before a scheduled procedure

• Tell every provider involved, early. Your surgeon, anesthesiologist, proceduralist (for an endoscopy or colonoscopy under sedation), and your GLP-1 prescriber should all know you’re taking orforglipron as soon as the procedure is scheduled — not the morning of.
• Follow their fasting and medication instructions exactly. If they give you specific pre-procedure instructions — a liquid-only diet the day before, a hold on your dose, or nothing different at all — follow that plan rather than a generic rule.
• Mention where you are in your dose schedule. If you’re still titrating up rather than at a stable maintenance dose, say so — it’s relevant context for your care team.
• Don’t wait until check-in to bring it up. Surgical and anesthesia teams plan around this information in advance; a same-day mention leaves less room to adjust the plan if needed.

This precaution isn’t unique to orforglipron

Delayed gastric emptying is a mechanism shared across GLP-1 receptor agonists, not something specific to orforglipron. Semaglutide, sold as the injectable Ozempic and Wegovy and the oral Rybelsus, and tirzepatide, sold as Mounjaro and Zepbound, work through related GLP-1 (and, for tirzepatide, GIP/GLP-1 dual) mechanisms and carry similar preoperative considerations.

	Orforglipron (Foundayo)	Semaglutide (Ozempic/Wegovy/Rybelsus)	Tirzepatide (Mounjaro/Zepbound)
Mechanism relevant to surgery	GLP-1 receptor agonist; slows gastric emptying	GLP-1 receptor agonist; slows gastric emptying	Dual GIP/GLP-1 receptor agonist; slows gastric emptying
Route	Oral, once daily	Injection weekly (Ozempic/Wegovy) or oral daily (Rybelsus)	Injection, weekly
Common GI side effects	Nausea, vomiting, constipation, diarrhea	Nausea, vomiting, diarrhea, constipation	Nausea, vomiting, diarrhea, constipation

If a specific procedure is on your calendar, ask your prescriber and your surgical team directly how your particular medication and dose factor into their plan — this table is a starting point for the conversation, not a substitute for it.

How this fits with the rest of orforglipron’s side effect profile

Delayed gastric emptying isn’t an isolated quirk — it’s the same mechanism behind the gastrointestinal side effects most people notice on orforglipron, like nausea, and it’s worth understanding alongside them. Our orforglipron side effects guide covers what those symptoms typically look like and when they tend to ease, and how orforglipron works goes deeper into the gastric-emptying and appetite mechanism itself. If you’re newer to the medication generally, the Foundayo guide is a good starting point.

An upcoming procedure is also one of the situations covered in what happens when you stop taking orforglipron, and because the drug lingers in your body for days after your last dose, how long orforglipron stays in your system is useful background for that same conversation with your surgical team.

Bottom line

Orforglipron slows gastric emptying, and the FDA label for FOUNDAYO flags rare but real reports of pulmonary aspiration in GLP-1 users undergoing procedures under general anesthesia or deep sedation — even in some who followed standard fasting instructions. The label is also clear that there’s no established, verified way to modify fasting or dosing to eliminate that risk. The one concrete action that’s actually grounded in the label: tell every provider involved in an upcoming surgery or procedure that you’re taking orforglipron, as early as you can, and follow the specific plan they give you rather than a generic rule.